What is Jupiter Neurosciences, Inc. Common Stock (JUNS) stock price today?

Jupiter Neurosciences, Inc. Common Stock (JUNS) currently trades at $0.38 per share. The stock has a market capitalization of $13.16M and a P/E ratio of —x.

Is JUNS stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Jupiter Neurosciences, Inc. Common Stock has a Smart Value Score of 15/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Jupiter Neurosciences, Inc. Common Stock's revenue and earnings?

Jupiter Neurosciences, Inc. Common Stock has trailing twelve-month (TTM) revenue of $21800.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.25.

JUNS

Jupiter Neurosciences, Inc. Common Stock

NASDAQ: JUNS · HEALTHCARE · BIOTECHNOLOGY

$0.38

+5.33% today

Updated 2026-04-30

Market cap

$13.16M

P/E ratio

—

P/S ratio

603.58x

EPS (TTM)

$-0.25

Dividend yield

—

52W range

$0 – $3

Volume

0.1M

Market cap

$13.16M

P/E ratio

—

P/S ratio

603.58x

EPS (TTM)

$-0.25

Dividend yield

—

52W range

$0 – $3

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.3

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$30.00

+7811.39%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-2.37M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$233281.00	$0.00	$0.00	$21796.00	$21800.00
Net income	$-4.96M	$-4.78M	$-2.44M	$-8.64M	$-2.58M
EPS	—	—	—	—	$-0.25
Free cash flow	$-1.25M	$-480956.00	$-3.91M	$-5.41M	$-2.37M
Profit margin	-2,125.15%	—	—	-39,662.77%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
JUNS	$13.16M	15	3.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Jupiter Neurosciences, Inc. Common Stock trades at $0.38. Our Smart Value Score of 15/100 indicates the stock is weak. TTM revenue stands at $21800.00.

Frequently asked questions

What is Jupiter Neurosciences, Inc. Common Stock's stock price?

Jupiter Neurosciences, Inc. Common Stock (JUNS) trades at $0.38.

Is Jupiter Neurosciences, Inc. Common Stock overvalued?

Smart Value Score 15/100 (Grade F, Strong Sell).

What is the price target of Jupiter Neurosciences, Inc. Common Stock (JUNS)?

The analyst target price is $30.00, representing +7811.4% upside from the current price of $0.38.

What is Jupiter Neurosciences, Inc. Common Stock's revenue?

TTM revenue is $21800.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio603.58x

ROE-739.00%

Beta—

50D MA$0.43

200D MA$1.08

Shares out0.04B

Float0.02B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

JUNS vs LLY →JUNS vs JNJ →JUNS vs ABBV →Stock screener →